Clinical Trial Update: Botulinum Toxin to Improve Results in Epicanthoplasty [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating botulinum toxin to improve results in epicanthoplasty for scar-related outcomes and intercanthal distance ratio.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intercanthal Distance Ratio Abnormality
• Scar Formation

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Scar, Intercanthal Distance Ratio | Phase 3 | Status: UNKNOWN